过敏性鼻炎管理中的数字健康工具:系统性审查
Abdullah D Alotaibi1, Abdulaziz S AlQahtani1, Mohammed Alateeq1
1Department of Otolaryngology, College of Medicine, University of Ha'il, Ha'il, Saudi Arabia.
概括
数字健康工具,包括人工智能,显著改善过敏性鼻炎 (AR) 管理. 这些干预措施增强了症状控制和药物坚持,为个性化患者护理提供了有前途的方法.
科学领域:
- 数字健康数字健康
- 人工智能的人工智能
- 过敏性鼻炎管理管理
背景情况:
- 过敏性鼻炎 (AR) 是一种IgE介导的疾病,对患者和医疗保健系统构成挑战.
- 目前的AR管理在症状跟踪,药物坚持和个性化护理方面扎.
研究的目的:
- 评估数字健康干预措施的有效性,特别是人工智能驱动的解决方案,以改善AR管理结果.
- 评估数字工具对症状控制,治疗坚持,患者满意度和诊断准确性的影响.
主要方法:
- 系统审查遵循PRISMA指南,搜索主要数据库 (PubMed,MEDLINE,科学网,Scopus) 从2010年到2025年.
- 包括关于数字方法的研究:移动应用,远程医疗,可穿戴设备,电子日记和医学中的AI.
- 分析的重点是报告的结果:症状控制,治疗计划的遵守,患者满意度和测试准确度.
主要成果:
- 包括120项研究 (80项RCT,30项观察性,10项定性) 在内.
- 数字系统表现出显著的改善:在症状管理方面达到82%,在药物坚持方面达到90%.
- 可穿戴设备提高了诊断准确性 (FeNO,鼻腔耐药性);远程医疗减少了访问和提高了满意度. 人工智能提供了实时,个性化的建议.
结论:
- 数字工具为管理过敏性鼻炎提供了可靠的方法.
- 建议将其与分子工具集成,并为临床医生实践实施,以实现更广泛的采用.
- 未来的研究应该专注于验证生物标志物并确保这些技术的公平应用.
相关概念视频
01:17Drugs Used in Lower Respiratory Disorders: Overview
629
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
629
01:30Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
01:16Drugs Used in Upper Respiratory Disorders: Overview
375
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
375
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
484
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
484
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
399
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
399
01:20Asthma: Pathogenesis and Management
618
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
618